Global ECG Patches and Holter Monitor Market - 2023-2030
Global ECG Patches and Holter Monitor Market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.
The trend towards ambulatory monitoring devices, technological advancements in the field, increase in investments for early detection of arrhythmia, and advancements in the field of telemetry will help the market to grow during the forecast period. The ECG patch is a small device that is connected to the body surface (commonly the chest) to process, acquire and transmit the electrical signal of the patient’s heart activity.
The information which was shown in monitor is later used for medical diagnostics (Holter monitors) or for displaying parameters such as heart rate in fitness activities. A Holter monitor test may be done if a traditional electrocardiogram (ECG or EKG) doesn't provide enough details about the heart's condition. If the irregular heartbeats are infrequent, a longer-term monitor called an event recorder may be needed.
Furthermore, the global ECG The Growing prevalence of cardiac arrhythmia, new device launches by key players, mergers and acquisitions with the companies, increasing demand for ambulatory monitoring devices, and technological advancements are likely to drive the market during the forecast period with having significant key players like Cardinal Health, Ambu, Hillrom (Baxter), Nihon Kohden, Koninklijke Philips N.V and others.
DynamicsRise in the Prevalence of Atrial Fibrillation
The rise in the prevalence of atrial fibrillation is one of the key factors that help the market to grow during the forecast period. Increase the prevalence will lead to high demand for ECG Patches and Holter monitor devices.
For instance, according to an updated article published in NCBI Atrial fibrillation is the most commonly encountered cardiac rhythm disorder. The prevalence of atrial fibrillation has been increasing worldwide. It is known that the prevalence of atrial fibrillation generally increases with age. It has been estimated that the number of individuals with atrial fibrillation will double or triple by the year 2050.
Although the worldwide prevalence of atrial fibrillation is approximately 1%, it is found in approximately 9% of individuals over the age of 75. At the age of 80, the lifetime risk of developing atrial fibrillation jumps to 22%. In addition, atrial fibrillation has more commonly been associated with males and is seen more often in whites as compared to blacks.
Rise in the Technological Advancements
The rise in the technological advancements is one of the key factors that helps the market to grow during the forecast period. One of the advancements in this market was Adhesive single-lead devices have been emerging over the last 20 years as an improved method of ECG remote monitoring. With their less obtrusive design and wear time of up to 14 days, these biosensor ‘patch’ technologies have been shown to outperform Holter monitors in diagnosing cardiac arrhythmias. ZIO by iRhythm (Zio) is an example of a continuous ambulatory monitoring patch technology used to detect cardiac arrhythmias. Also, numerous technologies have been evolved in Holter Technology and this technology will help the market to grow during the forecast period.
For instance, in November 2020 Vital Connect announced the Launch of VitalPatch RTM, a first-of-its-kind extended holter technology for cardiac monitoring. Vital Connect has launched its latest cardiac monitoring patch, the VitalPatch RTM, for patients who require extended Holter monitoring. The wearable biosensor looks for 21 different cardiac arrhythmias by using an artificial intelligence electrocardiogram sensor. It continuously monitors four significant vital signs: heart rate, heart rate variability, respiratory rate and activity.
Tedious And Outdated Holter ECG Analysis
Traditional Holter ECG analysis conducted manually by a cardiologist is complicated and requires a lot of effort. When a Holter examination is carried out, the nurse has to upload the raw signal from the Holter device to a computer, and then the physician creates their report, based on their current knowledge and experience. Thus, the doctor needs to be experienced, precise, and vigilant to be able to prepare such a report correctly.
Segment AnalysisThe global ECG Patches and Holter Monitor market is segmented based on device type, application, end-user and region.
The ECG Patches Segment From the Device Type Segment Accounted For Approximately 41.7% of ECG Patches and Holter Monitor Share
The ECG Patches segment from the device type segment accounted for 41.7% and it is expected to be dominated during the forecast period. A wearable ECG patch is equipped with an electrocardiography sensor and accelerometer to detect and record physiological data. Similar to smartwatches, ECG patches can be synced with a device such as a phone or a tablet to display the results.
For instance, in May 2023, VTT Technical Research Centre of Finland developed a new sustainable electrocardiogram (ECG, also known as EKG) patch that is fully recyclable and made of biomaterials. The device is modular, so electronic components can be easily removed from the disposable patch and used again.
The patch itself is made of nanocellulose and printed with carbon conductors and sensing electrodes. The biodegradable patch is made of VTT’s new material cellulose e-skin, which replaces traditional plastic in wearable skin applications.
Furthermore, in August 2022 SmartCardia, a leading MedTech company dedicated to strengthening the healthcare ecosystem, launched 7L patch, their 7-lead Cardiac Monitoring Patch in India. This state-of-the-art patch monitor combines medical wearable technology with AI to provide predictive and personalized patient insights through remote monitoring. The 7L patch is tracked by SmartCardia’s AI platform which is developed from millions of ECG segments interpreted by cardiologists and certified cardiac technicians and performs real-time detection of important arrhythmia events at cardiologist level accuracy.
Geographical PenetrationNorth America Accounted for Approximately 38.4% of the Market Share
North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the rising incidence of Atrial Fibrillation in the region, ageing population, technological advancements, mergers and acquisitions, shifting patient preference toward ambulatory ECG monitoring, the launch of next-generation wireless ECG monitoring devices, and technological collaborations between manufacturers.
For instance, in January 2021, Boston Scientific announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors – including short and long-term Holter monitors – to cardiac event monitors and mobile cardiac telemetry. The transaction consists of an upfront cash payment of $925 million, and up to an additional $300 million in a potential commercial milestone payment.
Competitive LandscapeThe major global players in the market include Cardinal Health, Ambu, Hillrom (Baxter), Nihon Kohden, Koninklijke Philips N.V., Koninklijke Philips N.V., SCHILLER, GE Healthcare, Henry Schein, Spacelabs Healthcare and among others.
COVID-19 Impact AnalysisCOVID-19 has positively impacted the market by increasing the use of ECG patches and Holter monitor devices for diagnosing, evaluating, and treating cardiac conditions. Patients with rhythm monitoring therapy are at a higher risk of developing severe diseases, leading to increased demand and growth in the market.
Also, the COVID-19 pandemic has resulted in high burden on public health and healthcare delivery globally. The disease has major effects on the cardiovascular system. A wide range of arrhythmias have been reported in patients, which complicate the course of COVID-19 due to the associated treatments.
Key Developments In May 2023 Vivalink, a leading provider of digital healthcare solutions, stated the newest version of its multi-parameter wearable electrocardiogram (ECG) patch with continuous 14-day live stream capabilities. With Vivalink's new patch, extended duration remote ECG monitoring can be performed with a single application of the patch, thereby reducing both clinician and patient burden. In addition, the real-time streaming capabilities let clinicians remotely view a patient's live ECG anywhere anytime.
In October 2022 Dozee, a healthcare startup that provides contactless remote patient- monitoring launched an easy-to-use ambulatory electrocardiogram (ECG) patch to monitor patients with cardiovascular disease (CVD). This ECG patch is to augment and play a key role in assisting health care professionals (HCPs) in identifying early signs of cardiac deterioration ensuring there is timely medical intervention, thereby improving patient safety.
In April 2022 B-Secur stated the launch of the FDA-cleared next-generation ECG cloud-based platform for use across Holter monitors, wearables and implantable devices. According to a company press release, the cloud-based software (Heart Key 2.0) reduces ECG signal noise, improving ECG interpretation for clinicians and facilitating the trend towards remote cardiac monitoring.
Why Purchase the Report?• To visualize the global ECG Patches and Holter Monitor market segmentation based on device type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global ECG Patches and Holter Monitor market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global ECG patches and Holter monitor market report would provide approximately 61 tables, 58 figures and 186 Pages.
Target Audience 2023• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies